Searching for glycomimetics that target protein misfolding in rare diseases: Successes, failures, and unexpected progress made in organic synthesis

Synlett

Volumn 25, Issue 9, 2014, Pages 1215-1240

  Compain, Philippe ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

C H functionalization; carbohydrates; glycosidases; multivalency; tandem reactions

Indexed keywords

CARBON; GLYCOSPHINGOLIPID; HYDROGEN; ORGANIC COMPOUND;

AMINATION; ARTICLE; CHEMICAL MODIFICATION; CHEMICAL PHENOMENA; COVALENT BOND; CYSTIC FIBROSIS; GAUCHER DISEASE; GLYCOMIMETIC; LYSOSOME STORAGE DISEASE; PROTEIN FOLDING; PROTEIN TARGETING; RARE DISEASE; REACTION ANALYSIS; STRUCTURE ANALYSIS; SYNTHESIS;

EID: 84901585405     PISSN: 09365214     EISSN: 14372096     Source Type: Journal    
DOI: 10.1055/s-0033-1340822     Document Type: Article

References (227)

1. Jacob, F. The Statue Within: An Autobiography; Cold Spring Harbor Laboratory Press: Woodbury. 1988. The original quotation in French is: Jaime les idées fixes à condition den changer.
2. Ellgaard, L.; Helenius, A. Nat. Rev. Mol. Cell Biol. 2003, 4, 181.
3. Campioni, S.; Monsellier, E.; Chiti, F. In Protein Misfolding Diseases: Current and Emerging Principles and Therapies; Ramirez-Alvarado, M.; Kelly, J. W.; Dobson, C. M., Eds.; Wiley: Hoboken, 2010, 3-20.
4. Cohen, F. E.; Kelly, J. W. Nature 2003, 426, 905.
5. Gavrin, L. K.; Denny, R. A.; Saiah, E. J. Med. Chem. 2012, 55, 10823.
6. Gomes, C. M. Curr. Top. Med. Chem. Sharjah, United Arab Emirate 2012, 12, 2460.
7. Norez, C.; Noel, S.; Wilke, M.; Bijvelds, M.; Jorna, H.; Melin, P.; DeJonge, H.; Becq, F. FEBS Lett. 2006, 580, 2081.
8. Tabcharani, J. A.; Chang, X. B.; Riordan, J. R.; Hanrahan, J. W. Nature 1991, 352, 628.
9. Gadsby D. C.; Nairn A. C. Physiol. Rev. 1999, 79, S77.
10. Kartner N.; Augustinas O.; Jensen T. J.; Naismith A. L.; Riordan J. R. Nat. Genet. 1992, 1, 321
11. Fan, J.-Q.; Ishii, S.; Asano, N.; Suzuki, Y. Nat. Med. 1999, 5, 112.
12. For recent reviews, see: Winchester, B.; Vellodi, A.; Young, E. Biochem. Soc. Trans. 2000, 28, 150.
13. Gregersen, N. J. Inherit. Metab. Dis. 2006, 29, 456.
14. Kolter, T.; Sandhoff, K. Biochim. Biophys. Acta 2006, 1758, 2057.
15. Raas-Rothshild, A.; Pankova-Kholmyansky, I.; Kacher, Y.; Futerman, A. H. Glycoconjugate J. 2004, 21, 295.
16. Wennekes, T.; van den Berg, R. J. B. H. N.; Boot, R. G.; van der Marel, G. A.; Overkleeft, H. S.; Aerts, J. M. F. G. Angew. Chem. Int. Ed. 2009, 48, 8848.
17. Platt, F. M.; Boland, B.; van der Spoel, A. C. J. Cell Biol. 2012, 199, 723.
18. Grabowski, G. A. Hematology Am. Soc. Hematol. Educ. Program 2012, 13; doi: 10.1182/asheducation-2012.1.13.
19. Fan, J.-Q. In Iminosugars: From Synthesis to Therapeutic Applications; Compain, P.; Martin, O. R., Eds.; Wiley-VCH: Weinheim, 2007, 225.
20. Fan, J.-Q. Trends Pharmacol. Sci. 2003, 24, 355.
21. Fan J.-Q. Biol. Chem. 2008, 389, 1.
22. Yu, Z.; Sawkar, A. R.; Kelly, J. W. FEBS J. 2007, 274, 4944.
23. Suzuki, Y.; Ogawa, S.; Sakakibara, Y. Perspect. Med. Chem. 2009, 3, 7.
24. Parenti, G. EMBO Mol. Med. 2009, 1, 268.
25. Desnick R. J. J. Inherit. Metab. Dis. 2004, 27, 385.
26. Beck, M. Expert Opin. Emerging Drugs 2010, 15, 495.
27. Sawkar, A. R.; DHaeze, W.; Kelly, J. W. Cell Mol. Life Sci. 2006, 63, 1179.
28. Valenzano, K. J.; Khanna, R.; Powe, Jr.A. C.; Boyd, R.; Lee, G.; Flanagan, J. J.; Benjamin, E. R. Assay Drug Dev. Technol. 2011, 9, 213.
29. Wrodnigg, T. M.; Stütz, A. E. Curr. Enzyme Inhib. 2012, 8, 47.
30. Benito, J. M.; García Fernández, J. M.; Ortiz Mellet, C. Expert Opin. Ther. Pat. 2011, 21, 885.
31. Boyd, R. E.; Lee, G.; Rybczynski, P.; Benjamin, E. R.; Khanna, R.; Wustman, B. A.; Valenzano, K. J. J. Med. Chem. 2013, 56, 2705.
32. Trapero, A.; Llebaria, A. Future Med. Chem. 2013, 5
33. Compain, P.; Desvergnes, V.; Liautard, V.; Pillard, C.; Toumieux, S. In Iminosugars: From Synthesis to Therapeutic Applications; Compain, P.; Martin, O. R., Eds.; Wiley-VCH: Weinheim, 2007, 327.
34. Compain, P.; Martin, O. R. Bioorg. Med. Chem. 2001, 9, 3077.
35. Ernst, B.; Magnani, J. L. Nat. Rev. Drug Discovery 2009, 8, 661.
36. Koester, D. C.; Dennis, C.; Holkenbrink, A.; Werz, D. B. Synthesis 2010, 3217.
37. Carbohydrate Mimics: Concepts and Methods; Chapleur, Y., Ed.; Wiley-VCH: Weinheim, 1998.
38. Quoted from: Smit, W. A.; Bochkov, A. F.; Caple, R. Organic Synthesis: The Science Behind the Art; Royal Society of Chemistry: Cambridge, 1998.
39. Hoffmann, R. J. Aesth. Art Crit. 1990, 48, 191.
40. Compain, P.; Desvergnes, V.; Ollivier, C.; Robert, F.; Suzenet, F.; Barboiu, M.; Belmont, P.; Blériot, Y.; Bolze, F.; Bouquillon, S.; Bourguet, E.; Braida, B.; Constantieux, T.; Désaubry, L.; Dupont, D.; Gastaldi, S.; Jérome, F.; Legoupy, S.; Marat, X.; Migaud, M.; Moitessier, N.; Papot, S.; Peri, F.; Petit, M.; Py, S.; Schulz, E.; Tranoy-Opalinski, I.; Vauzeilles, B.; Vayron, P.; Vergnes, L.; Vidal, S.; Wilmouth, S. New J. Chem. 2006, 30, 823.
41. Compain P. Actual. Chim. 2003, 263, 129.
42. Stütz, A. E. Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond; Wiley-VCH: Weinheim, 1999.
43. Compain, P.; Martin, O. R. Iminosugars: From Synthesis to Therapeutic Applications; Wiley-VCH: Weinheim, 2007.
44. Nicolaou, K. C.; Vourloumis, D.; Wissinger, N.; Baran, P. S. Angew. Chem. Int. Ed. 2000, 39, 44.
45. Fabrega, S.; Durand, P.; Codogno, P.; Bauvy, C.; Delomenie, C.; Henrissat, B.; Martin, B. M.; McKinney, C.; Ginns, E. I.; Mornon, J. P.; Lehn, P. Glycobiology 2000, 10, 1217.
46. Fabrega S.; Durand P.; Mornon J. P.; Lehn P. J. Soc. Biol. 2002, 196, 151.
47. Davies, C.; Henrissat, B. Structure (Cambridge, MA) 1995, 3, 853.
48. Special issue: Gauchers Disease, Baillières Clin. Haematol 1997, 10, 621.
49. Beutler, E.; Grabowski, G. In The Metabolic and Molecular Basis of Inherited Diseases; Scrivener, C.; Beaudet, A. L.; Sly, W. S.; Valle, D.; Childs, B.; Kinzler, K. W.; Vogelstein, B., Eds.; McGraw-Hill: New York, 2001, 8th ed. 3635.
50. Butters T. D. Curr. Opin. Chem. Biol. 2007, 11, 412.
51. Meikle, P. J.; Hopwood, J. J.; Clague, A. E.; Carey, W. F. JAMA, J. Amer. Med. Assoc. 1999, 281, 249.
52. Horowitz, M.; Zimran, A. Hum. Mutat. 1994, 3, 1.
53. Butters, T. D. In Iminosugars: from Synthesis to Therapeutic Applications; Compain, P.; Martin, O. R., Eds.; Wiley-VCH: Weinheim, 2007.
54. Aerts J. M.; Hollak C.; Boot R.; Groener A. Philos. Trans. R. Soc. B 2003, 358, 905.
55. Beck, M. Hum. Genet. 2007, 121, 1.
56. Futerman, A. H.; Sussman, J. L.; Horowitz, M.; Silman, I.; Zimran, A. Trends Pharmacol. Sci. 2004, 25, 147.
57. Platt, F. M. Glycobiology 2005, 15, 43R.
58. Mehta, A. Acta Paediatrica 2008, 97, 83.
59. Boustany, R. M. N. Nat. Rev. Neurol. 2013, 9, 583.
60. van Gelder, C. M.; Vollebregt, A. A. M.; Plug, I.; van der Ploeg, A. T.; Reuser, A. J. J. Expert Opin. Pharmacother. 2012, 13, 2281.
61. Wraith, J. E. J. Inherit. Metab. Dis. 2006, 29, 442.
62. Rohrbach, M.; Clarke, J. T. R. Drugs 2007, 67, 2697.
63. Ohashi, T. Pediatr. Endocrinol. Rev. 2012, 10, 26.
64. Lachmann, R. H. Curr. Opin. Pediatr. 2011, 23, 588.
65. Butters, T. D.; Dwek, R. A.; Platt, F. M. Chem. Rev. 2000, 100, 4683.
66. Lachmann, R. H.; Platt, F. M. Expert Opin. Invest. Drugs 2001, 10, 455.
67. Platt F. M.; Jeyakumar M.; Andersson U.; Heare T.; Dwek R. A.; Butters T. D. Phil. Trans. R. Soc. B 2003, 358, 947.
68. Platt, F. M.; Jeyakumar, M. Acta Paediatrica 2008, 97, 88.
69. Butters, T. D. Exp. Opin. Pharmacother. 2007, 8, 427.
70. Beutler, E. Mol. Genet. Metab. 2006, 88, 208.
71. Smid, B. E.; Aerts, J. M. F. G.; Boot, R. G.; Linthorst, G. E.; Hollak, C. E. M. Expert. Opin. Invest. Drugs 2010, 19, 1367.
72. Parenti, G.; Pignata, C.; Vajro, P.; Salerno, M. C. Int. J. Mol. Med. 2013, 31, 11.
73. Yam, G. H.-F.; Zuber, C.; Roth, J. FASEB J. 2005, 19
74. Kornhaber, G. J.; Tropak, M. B.; Maegawa, G. H.; Tuske, S. J.; Coales, S. J.; Mahuran, D. J.; Hamuro, Y. ChemBioChem 2008, 9, 2643.
75. Lieberman R. L.; Wustman B. A.; Huertas P.; Powe A. C.; Pine C. W. Nat. Chem. Biol., 2007, 3, 101.
76. Steet R.A.,Chung S.,Wustman B.,Powe A.,Do H. 2006 Proc. Natl.A. S. U. Sci. Acad.
77. Schmitz, M.; Alfalah, M.; Aerts, J. M. F. G.; Naim, H. Y.; Zimmer, K.-P. Int. J. Biochem. Cell Biol. 2005, 37, 2310.
78. Sawkar, A. R.; Schmitz, M.; Zimmer, K.-P.; Reczek, D.; Edmunds, T.; Balch, W. E.; Kelly, J. W. ACS Chem. Biol. 2006, 1, 235.
79. Wei, R. R.; Hughes, H.; Boucher, S.; Bird, J. J.; Guziewicz, N.; Van Patten, S. M.; Qiu, H.; Qun Pan, C.; Edmunds, T. J. Biol. Chem. 2011, 286, 299.
80. Babajani, G.; Tropak, M. B.; Mahuran, D. J.; Kermode, A. R. Mol. Genet. Metab. 2012, 106, 323.
81. Tang, L.; Coales, S. J.; Morrow, J. A.; Edmunds, T.; Hamuro, Y. ChemBioChem 2012, 13, 2243.
82. For discussions on the so-called threshold theory, see: Kolter, T.; Wendeler, M. ChemBioChem 2003, 4, 260.
83. Conzelmann, E.; Sandhoff, K. Dev. Neurosci. (Amsterdam.) 1983, 6, 58.
84. Leinekugel P.; Michel S.; Conzelmann E.; Sandhoff K. Hum. Genet. 1992, 88, 513.
85. Horne, G.; Wilson, F. X.; Tinsley, J.; Williams, D. H.; Storer, R. Drug Discovery Today 2011, 16, 107.
86. Germain, D. P.; Fan, J.-Q. Int. J. Clin. Pharmacol. Ther. 2009, 47, S111.
87. Martin, O. R.; Xie, F.; Liu, L. Tetrahedron Lett. 1995, 36, 4027.
88. Asano, N.; Ikeda, K.; Yasuda, K.; Kizu, H.; Kameda, Y.; Kato, A.; Okamato, T.; Ishii, S.; Compain, P.; Martin, O. R.; Fan, J.-Q. Glycoconjugate J. 1999, 16, S156.
89. Asano, N.; Ishii, S.; Kizu, H.; Ikeda, K.; Yasuda, K.; Kato, A.; Martin, O. R.; Fan, J.-Q. Eur. J. Biochem. 2000, 267, 4179.
90. Sawkar, A. R.; Cheng, W.-C.; Beutler, E.; Wong, C.-H.; Balch, W. E.; Kelly, J. W. Proc. Natl. Acad. Sci. U. S. A. 2002, 99, 15428.
91. Hodson, M. E. Respiration 2000, 67, 595.
92. Rosenstein, B. J.; Cutting, G. R. J. Pediatr. N. Y., NY U. S.. 1998, 132, 589.
93. Hamosh, A.; Fitz-Simmons, S. C.; Macek, M. Jr.; Knowles, M. R.; Rosenstein, B. J.; Cutting, G. R. J. Pediatr. N. Y., NY U. S.. 1998, 132, 255.
94. Farell P. M. J. Cyst. Fibros., 2008, 7, 450.
95. Lubamba, B.; Dhooghe, B.; Noel, S.; Leal, T. Clin. Biochem. 2012, 45, 1132.
96. Davis, P. B. Am. J. Respir. Crit. Care Med. 2006, 173, 475.
97. Becq, F.; Mall, M. A.; Sheppard, D. N.; Conese, M.; Zegarra-Moran, O. J. Cyst. Fibros. 2011, 10, S129.
98. Birault, V.; Solari, R.; Hanrahan, J.; Thomas, D. Y. Curr. Opin. Chem. Biol. 2013, 17, 353.
99. Molinski S.; Eckford P. D. W.; Pasyk S.; Ahmadi S.; Chin S.; Bear C. E. Front. Pharmacol. 2012, 3, 160; doi: 10.3389/fphar.2012.00160.
100. Merk, D.; Schubert-Zsilavecz, M. Expert Opin. Drug Discovery 2013, 8, 691.
101. Becq, F.; Mettey, Y. Expert Opin. Ther. Patents 2004, 14, 1465.
102. Hanrahan, J. W.; Sampson, H. M.; Thomas, D. Y. Trends Pharmacol. Sci. 2013, 34, 119.
103. Pedemonte N.; Galietta L. J. V. Front. Pharmacol. 2012, 3, 175; doi: 10.3389/fphar.2012.00175.
104. Rowe, S. M.; Verkman, A. S. Cold Spring Harb. Perspect. Med. 2013, 3, a009761.
105. Galietta, L. J. V. Pediatr. Drugs 2013, 15, 393; doi: 10.1007/s40272-013- 0035-3.
106. Wilschanski, M. Discov. Med. 2013, 15, 127.
107. Denning, G. M.; Anderson, M. P.; Amara, J. F.; Marshall, J.; Smith, A. E.; Welsh, M. J. Nature 1992, 358, 761.
108. Pedemonte, N.; Lukacs, G. L.; Du, K.; Caci, E.; Zegarra- Moran, O.; Galietta, L. J. V.; Verkman, A. S. J. Clin. Invest. 2005, 115, 2564.
109. Pind, S.; Riordan, J. R.; Williams, D. B. J. Biol. Chem. 1994, 269, 12784.
110. Helenius A.; Aebi M. Annu. Rev. Biochem. 2004, 73, 1019.
111. Ware F. E.; Vassilakos A.; Peterson P. A.; Jackson M. R.; Lehrman M. A.; Williams D. B. J. Biol. Chem. 1995, 270, 4697.
112. Noel, S.; Faveau, C.; Norez, C.; Rogier, C.; Mettey, Y.; Becq, F. J. Pharmacol. Exp. Ther. 2006, 319, 349.
113. Norez, C.; Antigny, F.; Noel, S.; Vandebrouck, C.; Becq, F. Am. J. Respir. Cell. Mol. Biol. 2009, 41, 217.
114. For a review on imino-C-glycosides, see: Compain, P.; Chagnault, V.; Martin, O. R. Tetrahedron: Asymmetry 2009, 20, 672.
115. Godin, G.; Compain, P.; Masson, G.; Martin, O. R. J. Org. Chem. 2002, 67, 6960.
116. Masson G.; Compain P.; Martin O. R. Org. Lett. 2000, 2, 2971.
117. Godin, G.; Compain, P.; Martin, O. R.; Ikeda, K.; Yu, L.; Asano, N. Bioorg. Med. Chem. Lett. 2004, 14, 5991.
118. Godin, G.; Compain, P.; Martin, O. R. Org. Lett. 2003, 5, 3269.
119. Godin, G.; Compain, P.; Martin, O. R. Synlett 2003, 2065.
120. Compain, P.; Martin, O. R.; Boucheron, C.; Godin, G.; Yu, L.; Ikeda, K.; Asano, N. ChemBioChem 2006, 7, 1356.
121. For improved syntheses of -1-C-alkyl-iminoxylitol derivatives, see: Oulaïdi, F.; Gallienne, E.; Compain, P.; Martin, O. R. Tetrahedron: Asymmetry 2011, 22, 609.
122. Biela, A.; Oulaïdi, F.; Gallienne, E.; Grecki, M.; Frelek, J.; Martin, O. R. Tetrahedron 2013, 69, 3348.
123. Boucheron, C.; Compain, P.; Martin, O. R. Tetrahedron Lett. 2006, 47, 3081.
124. Boucheron, C.; Desvergnes, V.; Compain, P.; Martin, O. R.; Lavi, A.; Mackeen, M.; Wormald, M. R.; Dwek, R. A.; Butters, T. D. Tetrahedron: Asymmetry 2005, 16, 1747.
125. Boucheron, C.; Toumieux, S.; Compain, P.; Martin, O. R.; Ikeda, K.; Asano, N. Carbohydr. Res. 2007, 342, 1960.
126. Butters, T. D.; van den Broek, L. A. G. M.; Fleet, G. W. J.; Krulle, T. M.; Wormald, M. R.; Dwek, R. A.; Platt, F. M. Tetrahedron: Asymmetry 2000, 11, 113.
127. Butters T. D.; Dwek R. A.; Platt F. M. Curr. Top. Med. Chem. Sharjah, United Arab Emirates. 2003, 3, 561.
128. The results obtained for the O-alkylated derivatives can be explained, in part, by the fact that the C2-hydroxyl group of the DNJ core is important for glycosylceramide synthase inhibition, as recently demonstrated; see: van den Berg, R. J. B. H. N.; Wennekes, T.; Ghisaidoobe, A.; Donker- Koopman, W. E.; Strijland, A.; Boot, R. G.; van der Marel, G. A.; Aerts, J. M. F. G.; Overkleeft, H. S. ACS Med. Chem. Lett. 2011, 2, 519.
129. Yu, L.; Ikeda, K.; Kato, A.; Adachi, I.; Godin, G.; Compain, P.; Martin, O. R.; Asano, N. Bioorg. Med. Chem. 2006, 14, 7736.
130. Bordier, A.; Compain, P.; Martin, O. R.; Ikeda, K.; Asano, N. Tetrahedron: Asymmetry 2003, 14, 47.
131. In 2005, Fan and co-workers reported the discovery of 6-C-nonylisofagomine, a very potent GCase inhibitor IC50 = 0.6 nM), see: Zhu, X.; Sheth, K. A.; Li, S.; Chang, H.-H.; Fan, J.-Q. Angew. Chem. Int. Ed. 2005, 44, 7450.
132. Schönemann, W.; Gallienne, E.; Compain, P.; Ikeda, K.; Asano, N.; Martin, O. R. Bioorg. Med. Chem. 2010, 18, 2645.
133. Mellor, H. R.; Platt, F. M.; Dwek, R. A.; Butters, T. D. Biochem. J. 2003, 374, 307.
134. Oulaïdi, F.; Front-Deschamps, S.; Gallienne, E.; Lesellier, E.; Ikeda, K.; Asano, N.; Compain, P.; Martin, O. R. ChemMedChem 2011, 6, 353.
135. Nocquet, P.-A.; Hazelard, D.; Compain, P. Eur. J. Org. Chem. 2011, 6619.
136. Nocquet, P.-A.; Hazelard, D.; Compain, P. Tetrahedron 2012, 68, 4117.
137. To our knowledge, only one example of the formation of a cyclobutane by a Dieckmann reaction has been reported in the literature, but no mention is given of the yield obtained; see: Chande, M. S.; Suryanarayan, V. Tetrahedron Lett. 2002, 43, 5173.
138. Hoye, T. R.; Dvornikovs, V.; Sizova, E. Org. Lett. 2006, 8, 5191.
139. Rietsch V.; Miesch L.; Yamashita D.; Miesch M. Eur. J. Org. Chem. 2010, 6944.
140. For recent examples, see: Kim, S.-Y.; Park, H.-B.; Cho, J.-H.; Yoo, K.-H.; Oh, C.-H. Bioorg. Med. Chem. Lett. 2009, 19, 2558.
141. Cianchetta, G.; Mannhold, R.; Cruciani, G.; Baroni, M.; Cecchetti, V. J. Med. Chem. 2004, 47, 3193.
142. Guo, Z.; Orth, P.; Wong, S.-C.; Lavey, B. J.; Shih, N.-Y.; Niu, X.; Lundell, D. J.; Madison, V.; Kozlowski, J. A. Bioorg. Med. Chem. Lett. 2009, 19, 54.
143. Couty, F.; Evano, G. Synlett 2009, 3053.
144. Van Brabandt W.; Van Landeghem R.; De Kimpe N. Org. Lett. 2006, 8, 1105.
145. Blakemore, D. C.; Chiva, J.-Y.; Thistlethwaite, I. Synlett 2011, 1101.
146. Mollet K.; Catak S.; Waroquier M.; Van Speybroeck V.; Dhooghe M.; De Kimpe N. J. Org. Chem. 2011, 76, 8364.
147. Mollet, K.; Broeckx, L.; Dhooghe, M.; De Kimpe, N. Heterocycles 2012, 84, 431.
148. Nocquet, P.-A.; Hazelard, D.; Compain, P. unpublished results.
149. For a synthesis of the carbasugar moiety of 28 by way of a stereoselective SmI2-mediated aldehyde-alkene cyclization, see: Nocquet, P.-A.; Hazelard, D.; Gruntz, G.; Compain, P. J. Org. Chem. 2013, 78, 6751.
150. For examples of intramolecular ring-opening reactions of Nalkylated azetidines with amines, see: Vargas-Sanchez, M.; Couty, F.; Evano, G.; Prim, D.; Marrot, J. Org. Lett. 2005, 7, 5861.
151. Espino, C. G.; Du Bois, J. Angew. Chem. Int. Ed. 2001, 40, 598.
152. Espino, C. G.; Wehn, P. M.; Chow, J.; Du Bois, J. J. Am. Chem. Soc. 2001, 123, 6935.
153. Breslow, R.; Gellman, S. H. J. Am. Chem. Soc. 1983, 105, 6728.
154. Dauban, P.; Saniére, L.; Tarrade, R. H.; Dodd, R. J. Am. Chem. Soc. 2001, 123, 7707.
155. Yu X.-Q.; Huang J.-S.; Zhou X.-G.; Che C.-M. Org. Lett. 2000, 2, 2233.
156. For comprehensive reviews, see: Du Bois, J. Chemtracts 2005, 18, 1.
157. Espino, C. G.; Du Bois, J. In Modern Rhodium-Catalyzed Organic Reaction; Evans, P. A., Ed.; Wiley-VCH: Weinheim, 2005, 379.
158. Müller P.; Fruit C. Chem. Rev. 2003, 103, 2905.
159. Dauban, P.; Dodd, R. H. Synlett 2003, 1571.
160. Dauban, P.; Dodd, R. In Amino Group Chemistry: From Synthesis to the Life Sciences; Ricci, A., Ed.; Wiley-VCH: Weinheim, 2007, 55.
161. Dick, A. R.; Sanford, M. S. Tetrahedron 2006, 62, 2439.
162. Li Z.; He C. Eur. J. Org. Chem. 2006, 4313
163. Davies, H. M. L.; Long, M. S. Angew. Chem. Int. Ed. 2005, 44, 3518.
164. Collet, F.; Dodd, R. H.; Dauban, P. Chem. Commun. 2009, 5061.
165. Compain, P.; Toumieux, P. In Targets in Heterocyclic Systems: Chemistry and Properties; Vol. 11; Attanasi, O. A.; Spinelli, D., Eds.; Royal Society of Chemistry: Cambridge, 2007, 338.
166. Collet F.; Lescot C.; Dauban P. Chem. Soc. Rev. 2011, 40, 1926.
167. Dequirez, G.; Pons, V.; Dauban, P. Angew. Chem. Int. Ed. 2012, 51, 7384.
168. Roizen J. L.; Harvey M. E.; Du Bois; J. Acc. Chem. Res. 2012, 45,. 911.
169. Meléndez, R. S.; Lubell, W. D. Tetrahedron 2003, 59, 2581.
170. Bower J. F.; Rujirawanich J.; Gallagher T. Org. Biomol. Chem. 2010, 8, 1505.
171. For a review on amino C-glycoside synthesis, see: Xie, J. Recent Res. Dev. Org. Chem. 1999, 3, 505.
172. Granier, T.; Vasella, A. Helv. Chim. Acta 1998, 81, 865.
173. Flemming, J. J.; Fiori, K. W.; Du Bois, J. J. Am. Chem. Soc. 2003, 125, 2028.
174. Toumieux, S.; Compain, P.; Martin, O. R. Tetrahedron Lett. 2005, 46, 4731.
175. Wardrop, D. J.; Zhang, W.; Fritz, J. Org. Lett. 2002, 4
176. Malatesta, V.; Ingold, K. U. J. Am. Chem. Soc. 1981, 103, 609.
177. Toumieux, S.; Compain, P.; Martin, O. R.; Selkti, M. Org. Lett. 2006, 8, 4493.
178. Johnson, F. Chem. Rev. 1968, 68, 375.
179. Hoffman R. W. Chem. Rev. 1989, 89, 1841.
180. Kuznetsov N. Y.; Khrustalev V. N.; Godovikov I. A.; Bubnov Y. N. Eur. J. Org. Chem. 2006, 113.
181. Cariou C. A. M.; Snaith J. S. Org. Biomol. Chem. 2006, 4, 51.
182. Jourdant, A.; Zhu, J. Tetrahedron Lett. 2000, 41, 7033.
183. Morin, M. S. T.; Toumieux, S.; Compain, P.; Peyrat, S.; Kalinowska-Tlusik, J. Tetrahedron Lett. 2007, 48, 8531.
184. Toumieux, S.; Compain, P.; Martin, O. R. J. Org. Chem. 2008, 73, 2155.
185. Wyszynski, F. J.; Thompson, A. L.; Davis, B. G. Org. Biomol. Chem. 2010, 8, 4246.
186. Milczek, E.; Boudet, N.; Blakey, S. Angew. Chem. Int. Ed. 2008, 47, 6825.
187. Trost B. M.; OBoyle B. M.; Torres W.; Ameriks M. K. Chem. Eur. J. 2011, 17, 7890.
188. Ranatunga, S.; Del Valle, J. R. Tetrahedron Lett. 2009, 50, 2464.
189. Rodríguez-Lucena, D.; Morin, M. S. T.; Compain, P. Lett. Org. Chem. 2011, 8, 155.
190. For a review on olefin metathesis of amine-containing systems, see: Compain, P. Adv. Synth. Catal. 2007, 349, 1829.
191. Cipolla, L.; Palma, A.; La Ferla, B.; Nicotra, F. J. Chem. Soc., Perkin Trans. 1 2002, 2161.
192. Decroocq, C.; Mamani Laparra, L.; Rodríguez-Lucena, D.; Compain, P. J. Carbohydr. Chem. 2011, 30, 559.
193. Iehl, J.; Nierengarten, J.-F. Chem. Eur. J. 2009, 15, 7306.
194. For the evaluation of multivalent glycosylated fullerenes as glycosyltransferase inhibitors or lectin ligands, see: Cecioni, S.; Oerthel, V.; Iehl, J.; Holler, M.; Goyard, D.; Praly, J.-P.; Imberty, A.; Nierengarten, J.-F.; Vidal, S. Chem. Eur. J. 2011, 17, 3252.
195. Durka M.; Buffet K.; Iehl J.; Holler M.; Nierengarten J.-F.; Vincent S. P. Chem. Eur. J. 2012, 18, 641.
196. Sánchez-Navarro M.; Muñoz A.; Illescas B. M.; Rojo J.; Martín N. Chem. Eur. J., 2011, 17, 766.
197. Lahmann, M. Top. Curr. Chem. 2009, 288, 17.
198. Deniaud, D.; Julienne, K.; Gouin, S. G. Org. Biomol. Chem. 2011, 9, 966.
199. Pieters R. J. Org. Biomol. Chem. 2009, 7, 2013.
200. Imberty A.; Chabre Y.; Roy R. Chem. Eur. J. 2008, 14, 7490.
201. Chabre Y. M.; Roy R. Adv. Carbohydr. Chem. Biochem. 2010, 63, 165.
202. Hartmann M.; Lindhorst T. K. Eur. J. Org. Chem. 2011, 3583.
203. Jayaraman, N. Chem. Soc. Rev. 2009, 38, 3463.
204. Martínez, A.; Ortiz Mellet, C.; García Fernández, J. M. Chem. Soc. Rev. 2013, 42, 4746.
205. Chabre Y. M.; Roy R. Chem. Soc. Rev. 2013, 42, 4657.
206. Choi, S.-K. Synthetic Multivalent Molecules: Concepts and Biomedical Applications; Wiley-VCH: Weinheim, 2004.
207. Kitov, P. I.; Sadowska, J. M.; Mulvey, G.; Armstrong, G. D.; Ling, H.; Pannu, N. S.; Read, R. J.; Bundle, D. R. Nature 2000, 403, 669.
208. Wennekes, T.; van der Berg, R. J. B. H. N.; Bonger, K. M.; Donker-Koopman, W. E.; Ghisaidoobe, A.; van der Marel, G. A.; Strijland, A.; Aerts, J. M. F. G.; Overkleeft, H. S. Tetrahedron: Asymmetry 2009, 20, 836.
209. Johns, B. A.; Johnson, C. R. Tetrahedron Lett. 1998, 39, 749.
210. Lohse, A.; Jensen, K. B.; Lundgren, K.; Bols, M. Bioorg. Med. Chem. 1999, 7, 1965.
211. McCort Y.; Saniére M.; Le Merrer Y. Tetrahedron 2003, 59, 2693.
212. Mammen, M.; Choi, S.-K.; Withesides, G. M. Angew. Chem. Int. Ed. 1998, 37, 2754.
213. Gestwicki J. E.; Cairo C. W.; Strong L. E.; Oetjen K. A.; Kiessling L. L. J. Am. Chem. Soc. 2002, 124, 14922.
214. Kiessling L.; Gestwicki J. E.; Strong L. E. Curr. Opin. Chem. Biol. 2000, 4, 696.
215. Diot, J.; Garcia-Moreno, M. I.; Gouin, S. G.; Ortiz Mellet, C.; Haupt, K.; Kovensky, J. Org. Biomol. Chem. 2009, 7, 357.
216. Compain, P.; Decroocq, C.; Iehl, J.; Holler, M.; Hazelard, D.; Mena Barragán, T.; Ortiz Mellet, C.; Nierengarten, J.-F. Angew. Chem. Int. Ed. 2010, 49, 5753.
217. Decroocq, C.; Rodríguez-Lucena, D.; Russo, V.; Mena Barragán, T.; Ortiz Mellet, C.; Compain, P. Chem. Eur. J. 2011, 17, 13825.
218. For studies on the mechanisms underlying the multivalent effect in glycosidase inhibition, see: Decroocq, C.; Joosten, A.; Sergent, R.; Mena Barragán, T.; Ortiz Mellet, C.; Compain, P. ChemBioChem 2013, 14, 2038.
219. Rísquez-Cuadro, R.; García Fernández, J. M.; Nierengarten, J.-F.; Ortiz Mellet, C. Chem. Eur. J. 2013, 19, 16791.
220. Brissonet Y.; Ortiz Mellet C.; Morandat S.; Garcia-Moreno M. I.; Deniaud D.; Matthews S. E.; Vidal S.; Sestak S.; El Kirat K.; Gouin S. G. J. Am. Chem. Soc. 2013, 135, 18427.
221. Decroocq, C.; Rodríguez-Lucena, D.; Ikeda, K.; Asano, N.; Compain, P. ChemBioChem 2012, 13, 661.
222. Joosten, A.; Decroocq, C.; de Sousa, J.; Schneider, J.; Etamé, E.; Bodlenner, A.; Butters, T. D.; Compain, P. ChemBioChem 2014, 15, 309.
223. Compain, P.; Decroocq, C.; Joosten, A.; de Sousa, J.; Rodríguez-Lucena, D.; Butters, T. D.; Bertrand, J.; Clément, R.; Boinot, C.; Becq, F.; Norez, C. ChemBioChem 2013, 14, 2050.
224. Overkleeft and co-workers have recently used ?-1-C-nonyliminoxylitol 14a as a chemical tool to elucidate the metabolism of glucosylceramide, see: Wennekes, T.; van den Berg, R. J. B. H. N.; Boltje, T. J.; Donker-Koopman, W. E.; Kuijper, B.; van der Marel, G. A.; Strijland, A.; Verhagen, C. P.; Aerts, J. M. F. G.; Overkleeft, H. S. Eur. J. Org. Chem. 2010, 1258.
225. Dekker, N.; Voorn-Brouwer, T.; Verhoek, M.; Wennekes, T.; Narayan, R. S.; Speijer, D.; Hollak, C. E. M.; Overkleeft, H. S.; Boot, R. G.; Aerts, J. M. F. G. Blood Cells, Mol., Dis. 2011, 46, 19.
226. Schönemann, W.; Gallienne, E.; Ikeda-Obatake, K.; Asano, N.; Nakagawa, S.; Kato, A.; Adachi, I.; Grecki, M.; Frelek, J.; Martin, O. R. ChemMedChem 2013, 8, 1805.
227. Very recently, it was demonstrated that CFTR correctors can also correct protein-folding diseases other than cystic fibrosis, see: Sampson, H. M.; Lam, H.; Chen, P.-C.; Zhang, D.; Mottillo, C.; Mirza, M.; Qasim, K.; Shrier, A.; Shyng, S.-L.; Hanrahan, J. W.; Thomas, D. Y. Orphanet J. Rare Dis. 2013, 8, 11.